Effective control of sickle cell disease with hydroxyurea therapy

OBJECTIVE: Hemoglobin F augmentation is another approach to treat sickle cell disease (SCD). This study evaluates the efficacy and impact of Hydroxyurea (HU) on fetal hemoglobin (HbF) and other hematological parameters, which result in decreasing the painful crisis and lower hospital admissions. MAT...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Singh, Harminder, Dulhani, Navin, Kumar, Bithika Nel, Singh, Prabhakar, Tiwari, Pawan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Medknow Publications 2010
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2885637/
https://ncbi.nlm.nih.gov/pubmed/20606834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.62409
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg